Judge OKs $486M Celebrex, Bextra Securities MDL Deal
A New York federal judge on Friday preliminarily approved Pfizer Inc.'s $486 million settlement resolving long-running multidistrict litigation accusing the company of misleading investors about the alleged risks of its pain...To view the full article, register now.
Already a subscriber? Click here to view full article